Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
Clinical trial NCT05062070 · COMPLETED
Trial details
- NCT number
- NCT05062070
- Sponsor
- BioMendics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2023-06-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.